Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1200
+0.0050 (4.35%)
Apr 23, 2025, 1:31 PM EDT
-47.83%
Market Cap 1.66M
Revenue (ttm) n/a
Net Income (ttm) -317.92K
Shares Out 13.86M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 544
Average Volume 18,068
Open 0.1200
Previous Close 0.1150
Day's Range 0.1200 - 0.1200
52-Week Range 0.0750 - 0.4500
Beta 1.53
RSI 41.11
Earnings Date Apr 28, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.